Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lixisenatide effects on gastric emptying and BP in T2D and healthy subjects
NCT02308254Phase 2Unknown
- Sponsor
- Royal Adelaide Hospital
- Start
- Nov 2013
- Primary completion
- Apr 2016
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 2 trial of lixisenatide in type 2 diabetes mellitus (T2DM), Postprandial hypotension (PPH), sponsored by Royal Adelaide Hospital. Status: unknown.
02
Drugs
lixisenatide
03
Conditions
type 2 diabetes mellitus (T2DM)Postprandial hypotension (PPH)
Beyond the preview
Go deeper on NCT02308254.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02308254.